FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208585924> ?p ?o ?g. }

• W3208585924 endingPage "8056" @default.
• W3208585924 startingPage "8049" @default.
• W3208585924 abstract "To evaluate the association of clinical outcomes with posttreatment changes in the relative eosinophil count (REC) and neutrophil-to-eosinophil ratio (NER) in patients with advanced urothelial cancer (UC) treated with pembrolizumab.We retrospectively analyzed 105 patients with advanced UC who received pembrolizumab after the failure of platinum-based chemotherapy. The REC and NER before and three weeks after pembrolizumab were recorded. A receiver operating characteristic curve was used to determine the optimal cut-off values for analyzing the risk.There were no significant differences in the overall survival (OS) between the REC ≥4.8% and <4.8% groups and the NER ≥13.7 and <13.7 groups before pembrolizumab (p=0.997 and 0.669, respectively). However, a significant difference in the OS was confirmed between the increased and decreased REC groups and between the decreased and increased NER groups at 3 weeks after pembrolizumab (p<0.001 and 0.002, respectively). Multivariate analyses revealed that an Eastern Cooperative Oncology Group Performance Status ≥2 (P=0.003), albumin <3.7 g/dl (p=0.002), LDH >246 U/L (p=0.011), disease site ≥3 organs (p=0.019), decreased posttreatment REC (3 weeks later) (p=0.002) and increased posttreatment NER (3 weeks later) (p=0.022) were independent prognostic factors for a worse OS.An increased REC and decreased NER after pembrolizumab may be significant early predictive markers of improved clinical outcomes in patients with advanced UC receiving pembrolizumab." @default.
• W3208585924 created "2021-11-08" @default.
• W3208585924 creator A5008310613 @default.
• W3208585924 creator A5011256581 @default.
• W3208585924 creator A5012284662 @default.
• W3208585924 creator A5012292098 @default.
• W3208585924 creator A5017068775 @default.
• W3208585924 creator A5020076297 @default.
• W3208585924 creator A5039626009 @default.
• W3208585924 creator A5045893818 @default.
• W3208585924 creator A5052095996 @default.
• W3208585924 creator A5071222216 @default.
• W3208585924 creator A5073793517 @default.
• W3208585924 creator A5082566636 @default.
• W3208585924 date "2021-10-01" @default.
• W3208585924 modified "2023-10-03" @default.
• W3208585924 title "The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab" @default.
• W3208585924 cites W1936755024 @default.
• W3208585924 cites W2019607817 @default.
• W3208585924 cites W2107863654 @default.
• W3208585924 cites W2154667937 @default.
• W3208585924 cites W2284518822 @default.
• W3208585924 cites W2397854274 @default.
• W3208585924 cites W2588916311 @default.
• W3208585924 cites W2767373080 @default.
• W3208585924 cites W2789677706 @default.
• W3208585924 cites W2896948312 @default.
• W3208585924 cites W2897038355 @default.
• W3208585924 cites W2911812451 @default.
• W3208585924 cites W2950551738 @default.
• W3208585924 cites W2955884544 @default.
• W3208585924 cites W3001445168 @default.
• W3208585924 cites W3010223451 @default.
• W3208585924 cites W3037612041 @default.
• W3208585924 cites W3047063889 @default.
• W3208585924 cites W3087464965 @default.
• W3208585924 cites W3087616846 @default.
• W3208585924 cites W3110035431 @default.
• W3208585924 cites W3125952181 @default.
• W3208585924 cites W3165458897 @default.
• W3208585924 doi "https://doi.org/10.2147/cmar.s333823" @default.
• W3208585924 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8554313" @default.
• W3208585924 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34729023" @default.
• W3208585924 hasPublicationYear "2021" @default.
• W3208585924 type Work @default.
• W3208585924 sameAs 3208585924 @default.
• W3208585924 citedByCount "8" @default.
• W3208585924 countsByYear W32085859242022 @default.
• W3208585924 countsByYear W32085859242023 @default.
• W3208585924 crossrefType "journal-article" @default.
• W3208585924 hasAuthorship W3208585924A5008310613 @default.
• W3208585924 hasAuthorship W3208585924A5011256581 @default.
• W3208585924 hasAuthorship W3208585924A5012284662 @default.
• W3208585924 hasAuthorship W3208585924A5012292098 @default.
• W3208585924 hasAuthorship W3208585924A5017068775 @default.
• W3208585924 hasAuthorship W3208585924A5020076297 @default.
• W3208585924 hasAuthorship W3208585924A5039626009 @default.
• W3208585924 hasAuthorship W3208585924A5045893818 @default.
• W3208585924 hasAuthorship W3208585924A5052095996 @default.
• W3208585924 hasAuthorship W3208585924A5071222216 @default.
• W3208585924 hasAuthorship W3208585924A5073793517 @default.
• W3208585924 hasAuthorship W3208585924A5082566636 @default.
• W3208585924 hasBestOaLocation W32085859242 @default.
• W3208585924 hasConcept C121608353 @default.
• W3208585924 hasConcept C126322002 @default.
• W3208585924 hasConcept C143998085 @default.
• W3208585924 hasConcept C2776042228 @default.
• W3208585924 hasConcept C2777037409 @default.
• W3208585924 hasConcept C2777701055 @default.
• W3208585924 hasConcept C2780057760 @default.
• W3208585924 hasConcept C2780352672 @default.
• W3208585924 hasConcept C3019882237 @default.
• W3208585924 hasConcept C58471807 @default.
• W3208585924 hasConcept C71924100 @default.
• W3208585924 hasConcept C90924648 @default.
• W3208585924 hasConceptScore W3208585924C121608353 @default.
• W3208585924 hasConceptScore W3208585924C126322002 @default.
• W3208585924 hasConceptScore W3208585924C143998085 @default.
• W3208585924 hasConceptScore W3208585924C2776042228 @default.
• W3208585924 hasConceptScore W3208585924C2777037409 @default.
• W3208585924 hasConceptScore W3208585924C2777701055 @default.
• W3208585924 hasConceptScore W3208585924C2780057760 @default.
• W3208585924 hasConceptScore W3208585924C2780352672 @default.
• W3208585924 hasConceptScore W3208585924C3019882237 @default.
• W3208585924 hasConceptScore W3208585924C58471807 @default.
• W3208585924 hasConceptScore W3208585924C71924100 @default.
• W3208585924 hasConceptScore W3208585924C90924648 @default.
• W3208585924 hasLocation W32085859241 @default.
• W3208585924 hasLocation W32085859242 @default.
• W3208585924 hasLocation W32085859243 @default.
• W3208585924 hasLocation W32085859244 @default.
• W3208585924 hasLocation W32085859245 @default.
• W3208585924 hasOpenAccess W3208585924 @default.
• W3208585924 hasPrimaryLocation W32085859241 @default.
• W3208585924 hasRelatedWork W2777867648 @default.
• W3208585924 hasRelatedWork W2786497694 @default.
• W3208585924 hasRelatedWork W2970048128 @default.
• W3208585924 hasRelatedWork W3093422519 @default.

• next